Impact of pain on the course of depressive and anxiety disorders

被引:141
作者
Gerrits, Marloes M. J. G. [1 ,2 ,3 ]
Vogelzangs, Nicole [1 ,2 ]
van Oppen, Patricia [1 ,2 ,3 ]
van Marwijk, Harm W. J. [1 ,2 ,3 ]
van der Horst, Henriette [3 ]
Penninx, Brenda W. J. H. [1 ,2 ,4 ,5 ]
机构
[1] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Psychiat, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] GGZ InGeest, Acad Outpatient Clin Affect Disorders, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Gen Practice, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands
关键词
Pain; Chronic pain; Depressive disorder; Anxiety disorder; Severity; Course; DIAGNOSTIC INTERVIEW CIDI; PRIMARY-CARE PATIENTS; MAJOR DEPRESSION; GENERAL-PRACTICE; RECURRENT DEPRESSION; TREATMENT RESPONSE; CONTROLLED-TRIAL; PERSISTENT PAIN; SOMATIC PAIN; DOUBLE-BLIND;
D O I
10.1016/j.pain.2011.11.001
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The combination of pain and depression or anxiety is commonly seen in clinical practice. Little is known about the influence of pain on psychopathology over time, as previous studies have been mainly crosssectional. The objectives of this study are to determine the impact of pain on the course of depressive and/ or anxiety disorders, and investigate to what extent the association between pain and course of these mental disorders is mediated by psychiatric characteristics. Data from the Netherlands Study of Depression and Anxiety (NESDA), collected between 2004 and 2009, were used. A total of 1209 participants with a depressive and/ or anxiety disorder at baseline were followed up for 2 years. Baseline pain was assessed by location, duration, use of pain medication, and severity (based on Chronic Pain Grade). Course of depressive and anxiety disorders was assessed by Composite International Diagnostic Interview (CIDI) and Life Chart Interview. A higher number of pain locations (OR = 1.10; P =.008), joint pain (OR = 1.64; P <.001), P90 days of pain (OR = 1.40; P =.009), daily use of pain medication (OR = 1.57; P =.047), and a higher Chronic Pain Grade score (OR = 1.27; P <.001) were associated with worse course of depressive and anxiety disorders. These associations were largely mediated by baseline severity of the mental disorder. However, joint pain remained associated with a worse course independent of baseline psychiatric characteristics. This study shows that patients with pain are more prone to a chronic course of depressive and anxiety disorders. More attention to pain seems to be necessary when diagnosing and treating these disorders. Future research should focus on treatment modalities for this co-occurrence, with joint pain in particular. (C) 2011 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:429 / 436
页数:8
相关论文
共 67 条
[31]   PAIN PERCEPTION IN PSYCHIATRIC-DISORDERS - A REVIEW OF THE LITERATURE [J].
LAUTENBACHER, S ;
KRIEG, JC .
JOURNAL OF PSYCHIATRIC RESEARCH, 1994, 28 (02) :109-122
[32]   Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report [J].
Leuchter, A. F. ;
Husain, M. M. ;
Cook, I. A. ;
Trivedi, M. H. ;
Wisniewski, S. R. ;
Gilmer, W. S. ;
Luther, J. F. ;
Fava, M. ;
Rush, A. J. .
PSYCHOLOGICAL MEDICINE, 2010, 40 (02) :239-251
[33]   Effect of improving depression care on pain and functional outcomes among older adults with arthritis -: A randomized controlled trial [J].
Lin, EHB ;
Katon, W ;
Von Korff, M ;
Tang, LQ ;
Williams, JW ;
Kroenke, K ;
Hunkeler, E ;
Harpole, L ;
Hegel, M ;
Arean, P ;
Hoffing, M ;
Della Penna, R ;
Langston, C ;
Unützer, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (18) :2428-2434
[34]  
LYKETSOS CG, 1994, INT J METHOD PSYCH, V4, P143
[35]   The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression [J].
Maes, Michael ;
Yirmiya, Raz ;
Noraberg, Jens ;
Brene, Stefan ;
Hibbeln, Joe ;
Perini, Giulia ;
Kubera, Marta ;
Bob, Petr ;
Lerer, Bernard ;
Maj, Mario .
METABOLIC BRAIN DISEASE, 2009, 24 (01) :27-53
[36]   BRIEF STANDARD SELF-RATING FOR PHOBIC PATIENTS [J].
MARKS, IM ;
MATHEWS, AM .
BEHAVIOUR RESEARCH AND THERAPY, 1979, 17 (03) :263-267
[37]   Relationships among pain, anxiety, and depression in primary care [J].
Means-Christensen, Adrienne J. ;
Roy-Byrne, Peter P. ;
Sherbourne, Cathy D. ;
Craske, Michelle G. ;
Stein, Murray B. .
DEPRESSION AND ANXIETY, 2008, 25 (07) :593-600
[38]   Comorbid Chronic Pain and Depression: Who Is at Risk? [J].
Miller, Lisa Renee ;
Cano, Annmarie .
JOURNAL OF PAIN, 2009, 10 (06) :619-627
[39]   The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine [J].
Müller, N ;
Schwarz, MJ ;
Dehning, S ;
Douhe, A ;
Cerovecki, A ;
Goldstein-Müller, B ;
Spellmann, I ;
Hetzel, G ;
Maino, K ;
Kleindienst, N ;
Möller, HJ ;
Arolt, V ;
Riedel, M .
MOLECULAR PSYCHIATRY, 2006, 11 (07) :680-684
[40]   Comorbid Pain, Depression, and Anxiety: Multifaceted Pathology Allows for Multifaceted Treatment [J].
Nicolson, Stephen E. ;
Caplan, Jason P. ;
Williams, Deldre E. ;
Stern, Theodore A. .
HARVARD REVIEW OF PSYCHIATRY, 2009, 17 (06) :407-420